Every material Form 8-K BXP filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
BXP, Inc. reported third-quarter 2026 results for the period ended September 30, 2026, with net income attributable to BXP of $114.5 million, or $0.71 per diluted share, compared with $68.6 million, or $0.43 per diluted share, in the prior quarter. Revenue rose to $911.4 million from $895.7 million, and diluted FFO per share increased to $1.89 from $1.78. The company also reiterated full-year 2026 guidance of $2.35 to $2.37 in diluted EPS and $7.06 to $7.08 in diluted FFO per share.
Q3 2026 net income attributable to BXP was $114.5 million, or $0.71 per diluted share, versus $68.6 million, or $0.43, in Q2 2026.
Total revenue was $911.4 million, up from $895.7 million in Q2 2026; FFO attributable to BXP was $302.2 million, up from $283.4 million.
Full-year 2026 guidance: projected diluted EPS of $2.35 to $2.37 and diluted FFO per share of $7.06 to $7.08.
Q3 2026 included a $6.0 million accelerated vesting charge in Q2 2026 and a $0.7 million deferred compensation gain in G&A; Q2 2026 included an $18.0 million impairment loss.
BXP reported second quarter 2026 results on July 28, 2026, with revenue of $895.7 million and diluted FFO of $1.78 per share, both up from the first quarter. Net income attributable to BXP fell to $68.6 million, or $0.43 per share, from $101.6 million, or $0.64 per share, in the first quarter, which included larger gains on sales. The company also gave full-year 2026 diluted FFO guidance of $6.99 to $7.05 per share and third-quarter guidance of $1.80 to $1.82.
Revenue rose to $895.7 million from $872.1 million in the first quarter of 2026.
Diluted FFO per share was $1.78, up from $1.59; FFO attributable to BXP was $283.4 million, up from $252.2 million.
Net income attributable to BXP was $68.6 million, or $0.43 per share, down from $0.64 per share; an $18.0 million impairment on the Sumner Square leasehold in Washington, DC was recorded.
Full-year 2026 guidance is $2.14 to $2.24 diluted EPS and $6.99 to $7.05 diluted FFO per share; third-quarter guidance is $0.50 to $0.52 EPS and $1.80 to $1.82 FFO per share.
On May 27, 2026, a BXP subsidiary agreed to sell three Washington, DC buildings on Sumner Square for a gross price of $63 million, as part of the asset sales plan from its September 2025 Investor Day. Because the property's carrying value exceeds expected net proceeds, BXP will record a non-cash impairment loss of approximately $18 million in the second quarter of 2026, which the company expects to cut earnings per diluted share by about $0.10 but not affect Funds from Operations. The sale is not assured to close on current terms.
Gross purchase price of $63 million for the Sumner Square leasehold and three buildings in Washington, DC
Non-cash impairment loss of approximately $18 million at BXP, Inc. and $17 million at BPLP, recorded in Q2 2026
Expected reduction of about $0.10 per diluted share/unit to net income for Q2 and full-year 2026; no impact on Funds from Operations
Buyer paid a non-refundable cash deposit of approximately $6 million, to be credited at closing
BXP, Inc. reported results for the quarter ended March 31, 2026, furnishing a press release and supplemental data on April 28, 2026. Net income attributable to BXP fell to $101.6 million, or $0.64 per diluted share, from $248.5 million, or $1.56 per share, in the prior quarter, and diluted FFO per share fell to $1.59 from $1.76. The filing also sets Q2 2026 and full-year 2026 guidance, but it does not state whether these ranges changed from earlier guidance.
Net income attributable to BXP, Inc.: $101.6 million, or $0.64 per diluted share, for the quarter ended March 31, 2026, versus $248.5 million, or $1.56 per share, for the quarter ended December 31, 2025.
Diluted FFO per share: $1.59, versus $1.76 in the prior quarter.
Total revenue: $872.1 million, versus $877.1 million in the prior quarter.
Guidance: Q2 2026 diluted EPS of $0.44 to $0.46 and FFO of $1.69 to $1.71 per share; full-year 2026 EPS of $2.15 to $2.29 and FFO of $6.90 to $7.04 per share.
BXP reported fourth-quarter and full-year 2025 results on January 27, 2026. Net income attributable to BXP was $248.5 million, or $1.56 per diluted share, compared with a loss of $121.7 million in the third quarter, and diluted FFO per share rose to $1.76 from $1.74. The company also issued 2026 guidance of $2.08 to $2.29 in diluted EPS and $6.88 to $7.04 in diluted FFO per share, though funds available for distribution fell to $134.5 million from $201.8 million.
Q4 2025 net income attributable to BXP was $248.5 million, or $1.56 per diluted share, versus a loss of $121.7 million, or $0.77 per share, in Q3 2025.
Q4 2025 revenue was $877.1 million, up from $871.5 million, and diluted FFO per share was $1.76, up from $1.74.
Full-year 2026 guidance: diluted EPS of $2.08 to $2.29 and diluted FFO per share of $6.88 to $7.04.
Funds available for distribution fell to $134.5 million from $201.8 million, and the FAD payout ratio rose to 92.09% from 61.37%.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every BXP filing is on SEC EDGAR ↗. 8-K briefs of other companies →